Mark Opp
Concepts (361)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sleep | 61 | 2016 | 632 | 7.600 |
Why?
| Wakefulness | 27 | 2014 | 128 | 3.590 |
Why?
| Sleep Wake Disorders | 9 | 2019 | 233 | 2.830 |
Why?
| Body Temperature | 32 | 2016 | 208 | 2.390 |
Why?
| Interleukin-1 | 34 | 2015 | 966 | 2.190 |
Why?
| Sleep, REM | 23 | 2016 | 50 | 1.960 |
Why?
| Brain | 33 | 2016 | 2374 | 1.770 |
Why?
| Corticotropin-Releasing Hormone | 13 | 2005 | 67 | 1.640 |
Why?
| Cytokines | 20 | 2020 | 1843 | 1.580 |
Why?
| Sleep Deprivation | 10 | 2016 | 166 | 1.560 |
Why?
| Fever | 13 | 2013 | 279 | 1.550 |
Why?
| Sleep Stages | 19 | 2016 | 61 | 1.430 |
Why?
| Myalgia | 3 | 2014 | 15 | 1.400 |
Why?
| Electroencephalography | 28 | 2016 | 362 | 1.390 |
Why?
| Immune System | 4 | 2015 | 173 | 1.220 |
Why?
| Interleukin-6 | 11 | 2014 | 675 | 1.140 |
Why?
| Hyperalgesia | 4 | 2014 | 107 | 1.090 |
Why?
| Sepsis | 4 | 2015 | 508 | 1.070 |
Why?
| Animals | 100 | 2018 | 31761 | 1.050 |
Why?
| Lipopolysaccharides | 7 | 2016 | 812 | 0.930 |
Why?
| Astrocytes | 2 | 2016 | 162 | 0.900 |
Why?
| Receptors, Corticotropin-Releasing Hormone | 7 | 2005 | 32 | 0.900 |
Why?
| Mice, Inbred C57BL | 19 | 2018 | 4710 | 0.840 |
Why?
| Rats, Sprague-Dawley | 33 | 2014 | 2209 | 0.840 |
Why?
| Neurons | 8 | 2016 | 1281 | 0.830 |
Why?
| Receptors, Interleukin-1 Type I | 2 | 2016 | 22 | 0.830 |
Why?
| Serotonin | 7 | 2009 | 291 | 0.770 |
Why?
| Rats | 43 | 2014 | 4943 | 0.770 |
Why?
| Mice | 30 | 2018 | 14916 | 0.710 |
Why?
| Immunity, Innate | 3 | 2016 | 723 | 0.650 |
Why?
| Tumor Necrosis Factor-alpha | 10 | 2015 | 1134 | 0.640 |
Why?
| Receptors, Interleukin-1 | 5 | 2015 | 227 | 0.640 |
Why?
| Disease Models, Animal | 10 | 2018 | 3542 | 0.640 |
Why?
| Orexins | 1 | 2018 | 4 | 0.640 |
Why?
| Psychoneuroimmunology | 3 | 2009 | 11 | 0.640 |
Why?
| Injections, Intraventricular | 23 | 2008 | 71 | 0.610 |
Why?
| 5-Hydroxytryptophan | 3 | 2008 | 22 | 0.610 |
Why?
| Behavior, Animal | 11 | 2013 | 460 | 0.600 |
Why?
| Vaccines | 1 | 2023 | 375 | 0.600 |
Why?
| Herpesviridae Infections | 2 | 2011 | 138 | 0.590 |
Why?
| Male | 71 | 2018 | 55579 | 0.550 |
Why?
| Fatigue | 2 | 2023 | 295 | 0.520 |
Why?
| Arousal | 9 | 2008 | 152 | 0.510 |
Why?
| Immunomodulation | 1 | 2016 | 84 | 0.490 |
Why?
| Illness Behavior | 2 | 2012 | 10 | 0.480 |
Why?
| Blood-Brain Barrier | 1 | 2015 | 106 | 0.480 |
Why?
| Diet, High-Fat | 1 | 2016 | 225 | 0.470 |
Why?
| Interleukin-1beta | 4 | 2012 | 370 | 0.470 |
Why?
| Mice, Knockout | 11 | 2018 | 2582 | 0.470 |
Why?
| Myositis | 1 | 2014 | 44 | 0.460 |
Why?
| Interleukin-10 | 5 | 2001 | 296 | 0.450 |
Why?
| Brain Injuries, Traumatic | 1 | 2018 | 300 | 0.450 |
Why?
| Pituitary Gland | 4 | 2003 | 148 | 0.440 |
Why?
| Housing, Animal | 1 | 2014 | 43 | 0.440 |
Why?
| Body Temperature Regulation | 5 | 2008 | 72 | 0.430 |
Why?
| Receptors, Tumor Necrosis Factor, Type I | 2 | 2014 | 72 | 0.420 |
Why?
| Body Weight | 3 | 2013 | 869 | 0.400 |
Why?
| Fatigue Syndrome, Chronic | 1 | 2011 | 16 | 0.370 |
Why?
| Glucose | 1 | 2016 | 897 | 0.370 |
Why?
| Motor Activity | 5 | 2014 | 640 | 0.370 |
Why?
| Gammaherpesvirinae | 2 | 2011 | 38 | 0.360 |
Why?
| Circadian Rhythm | 7 | 2011 | 355 | 0.360 |
Why?
| Virus Latency | 1 | 2011 | 80 | 0.350 |
Why?
| HIV Envelope Protein gp160 | 2 | 2000 | 7 | 0.350 |
Why?
| Gastrointestinal Microbiome | 1 | 2016 | 501 | 0.350 |
Why?
| Social Behavior | 1 | 2012 | 268 | 0.350 |
Why?
| Aging | 3 | 2015 | 1620 | 0.330 |
Why?
| Hypothalamus | 6 | 2014 | 147 | 0.320 |
Why?
| Neuroimmunomodulation | 4 | 2008 | 70 | 0.320 |
Why?
| RNA, Messenger | 6 | 2004 | 2557 | 0.320 |
Why?
| Inflammation | 2 | 2016 | 2481 | 0.320 |
Why?
| Rabbits | 18 | 2006 | 736 | 0.310 |
Why?
| Corticosterone | 6 | 2014 | 211 | 0.310 |
Why?
| Stress, Physiological | 3 | 2004 | 379 | 0.310 |
Why?
| Animal Welfare | 1 | 2008 | 13 | 0.310 |
Why?
| Polysaccharides | 1 | 2008 | 78 | 0.300 |
Why?
| Luminescent Measurements | 1 | 2008 | 74 | 0.300 |
Why?
| Hypothermia | 2 | 2005 | 38 | 0.300 |
Why?
| Receptor, Serotonin, 5-HT1A | 1 | 2008 | 39 | 0.290 |
Why?
| Drug Evaluation, Preclinical | 1 | 2008 | 165 | 0.290 |
Why?
| Dose-Response Relationship, Drug | 12 | 2008 | 1846 | 0.270 |
Why?
| Adrenal Glands | 2 | 2003 | 67 | 0.260 |
Why?
| Epstein-Barr Virus Infections | 1 | 2007 | 72 | 0.260 |
Why?
| Caspase Inhibitors | 1 | 2006 | 78 | 0.250 |
Why?
| Caspase 1 | 1 | 2006 | 140 | 0.250 |
Why?
| Drinking | 2 | 2016 | 33 | 0.240 |
Why?
| Time Factors | 8 | 2015 | 6124 | 0.240 |
Why?
| Neurophysiology | 1 | 2004 | 13 | 0.240 |
Why?
| Peptide Fragments | 9 | 2002 | 668 | 0.230 |
Why?
| Gene Expression Regulation | 2 | 2016 | 2321 | 0.230 |
Why?
| Sialoglycoproteins | 4 | 2004 | 158 | 0.230 |
Why?
| Mice, Transgenic | 5 | 2016 | 1951 | 0.220 |
Why?
| Oligonucleotides, Antisense | 1 | 2004 | 100 | 0.220 |
Why?
| Nervous System Physiological Phenomena | 1 | 2003 | 21 | 0.220 |
Why?
| Brain Chemistry | 1 | 2003 | 116 | 0.220 |
Why?
| Chronic Disease | 3 | 2014 | 1590 | 0.210 |
Why?
| Species Specificity | 4 | 2008 | 545 | 0.210 |
Why?
| Meta-Analysis as Topic | 1 | 2023 | 161 | 0.200 |
Why?
| Delta Rhythm | 4 | 1999 | 4 | 0.200 |
Why?
| Humans | 33 | 2023 | 114756 | 0.190 |
Why?
| Vagotomy | 2 | 1998 | 34 | 0.190 |
Why?
| Photoperiod | 3 | 2011 | 48 | 0.190 |
Why?
| gamma-Aminobutyric Acid | 3 | 2011 | 144 | 0.180 |
Why?
| AIDS Dementia Complex | 1 | 2000 | 50 | 0.180 |
Why?
| Irritable Bowel Syndrome | 1 | 2020 | 29 | 0.170 |
Why?
| Contraceptive Agents | 1 | 2020 | 54 | 0.170 |
Why?
| HIV Envelope Protein gp41 | 1 | 1999 | 6 | 0.170 |
Why?
| Subarachnoid Hemorrhage | 1 | 2019 | 60 | 0.170 |
Why?
| Motivation | 1 | 2023 | 494 | 0.160 |
Why?
| Ritanserin | 1 | 1999 | 1 | 0.160 |
Why?
| HIV | 1 | 2000 | 208 | 0.160 |
Why?
| Serotonin Antagonists | 1 | 1999 | 30 | 0.160 |
Why?
| Receptors, Serotonin | 1 | 1999 | 32 | 0.160 |
Why?
| Tryptophan | 1 | 2000 | 135 | 0.160 |
Why?
| Public Health | 1 | 2023 | 434 | 0.160 |
Why?
| Central Nervous System | 1 | 2000 | 237 | 0.160 |
Why?
| Proto-Oncogene Proteins c-fos | 2 | 2011 | 164 | 0.150 |
Why?
| Bacterial Infections | 3 | 2009 | 219 | 0.150 |
Why?
| Antibodies | 3 | 1994 | 371 | 0.140 |
Why?
| Physical Stimulation | 2 | 2014 | 77 | 0.140 |
Why?
| Walking | 1 | 2001 | 422 | 0.140 |
Why?
| Proteins | 3 | 2005 | 912 | 0.140 |
Why?
| Pyrogens | 2 | 1997 | 55 | 0.140 |
Why?
| Self Efficacy | 1 | 2019 | 355 | 0.130 |
Why?
| Brain Stem | 3 | 2010 | 101 | 0.130 |
Why?
| Hypothalamo-Hypophyseal System | 4 | 2014 | 165 | 0.130 |
Why?
| HIV Envelope Protein gp120 | 1 | 1996 | 56 | 0.130 |
Why?
| Vasculitis | 2 | 2007 | 70 | 0.130 |
Why?
| Hormone Antagonists | 3 | 2001 | 33 | 0.130 |
Why?
| Receptors, Chemokine | 1 | 2015 | 43 | 0.130 |
Why?
| Glial Fibrillary Acidic Protein | 1 | 2016 | 79 | 0.130 |
Why?
| Rats, Inbred F344 | 4 | 2014 | 241 | 0.120 |
Why?
| Interleukin-1 Receptor Accessory Protein | 1 | 2014 | 9 | 0.120 |
Why?
| Preoptic Area | 2 | 2004 | 5 | 0.120 |
Why?
| Vaccination | 1 | 2023 | 1205 | 0.120 |
Why?
| Raphe Nuclei | 2 | 2007 | 110 | 0.120 |
Why?
| Glucose Tolerance Test | 1 | 2016 | 343 | 0.120 |
Why?
| Cerebral Cortex | 4 | 2014 | 381 | 0.120 |
Why?
| Action Potentials | 3 | 2007 | 406 | 0.120 |
Why?
| Eye Movements | 2 | 2005 | 53 | 0.120 |
Why?
| Injections, Intraperitoneal | 2 | 2013 | 100 | 0.120 |
Why?
| Darkness | 1 | 2014 | 23 | 0.110 |
Why?
| Light | 2 | 2014 | 336 | 0.110 |
Why?
| Eating | 2 | 2016 | 345 | 0.110 |
Why?
| Neurotransmitter Agents | 1 | 2014 | 76 | 0.110 |
Why?
| Rats, Inbred Lew | 3 | 2014 | 92 | 0.110 |
Why?
| Gas Chromatography-Mass Spectrometry | 1 | 2013 | 125 | 0.110 |
Why?
| Paclitaxel | 1 | 2014 | 190 | 0.110 |
Why?
| Pituitary-Adrenal System | 3 | 2014 | 131 | 0.110 |
Why?
| Influenza A Virus, H1N1 Subtype | 1 | 2014 | 139 | 0.110 |
Why?
| Housing | 1 | 2014 | 114 | 0.100 |
Why?
| alpha-MSH | 2 | 1990 | 5 | 0.100 |
Why?
| Neuroglia | 1 | 2013 | 150 | 0.100 |
Why?
| Plasma | 1 | 2013 | 210 | 0.100 |
Why?
| Cecum | 1 | 2011 | 32 | 0.100 |
Why?
| Injections, Intravenous | 2 | 2004 | 201 | 0.100 |
Why?
| Up-Regulation | 2 | 2012 | 812 | 0.100 |
Why?
| Ligation | 1 | 2011 | 75 | 0.100 |
Why?
| Punctures | 1 | 2011 | 36 | 0.100 |
Why?
| Data Interpretation, Statistical | 1 | 2013 | 322 | 0.100 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 2013 | 473 | 0.100 |
Why?
| Infarction, Middle Cerebral Artery | 1 | 2011 | 38 | 0.090 |
Why?
| Interleukins | 2 | 1992 | 236 | 0.090 |
Why?
| Analysis of Variance | 4 | 2015 | 1226 | 0.090 |
Why?
| Tandem Mass Spectrometry | 1 | 2013 | 413 | 0.090 |
Why?
| Stress, Psychological | 2 | 2014 | 944 | 0.090 |
Why?
| Electrophysiology | 2 | 2009 | 201 | 0.090 |
Why?
| Receptors, Immunologic | 1 | 1992 | 201 | 0.090 |
Why?
| Glutamate Decarboxylase | 1 | 2011 | 160 | 0.090 |
Why?
| Homeostasis | 1 | 2014 | 575 | 0.090 |
Why?
| Growth Hormone-Releasing Hormone | 4 | 2005 | 26 | 0.090 |
Why?
| Virus Diseases | 2 | 2009 | 195 | 0.090 |
Why?
| Gene Expression | 3 | 2003 | 1420 | 0.090 |
Why?
| Arcuate Nucleus of Hypothalamus | 1 | 1990 | 13 | 0.090 |
Why?
| Sodium Glutamate | 1 | 1990 | 7 | 0.090 |
Why?
| Tegmentum Mesencephali | 1 | 2010 | 4 | 0.090 |
Why?
| Brain Injuries | 1 | 2015 | 452 | 0.090 |
Why?
| HIV-1 | 1 | 1996 | 768 | 0.090 |
Why?
| Neurosecretory Systems | 1 | 1990 | 32 | 0.090 |
Why?
| Immunohistochemistry | 2 | 2011 | 1635 | 0.080 |
Why?
| Metabolomics | 1 | 2013 | 527 | 0.080 |
Why?
| Cyclooxygenase 2 | 1 | 2009 | 164 | 0.080 |
Why?
| Cerebral Ventricles | 1 | 1988 | 47 | 0.080 |
Why?
| Biomarkers | 2 | 2020 | 3416 | 0.080 |
Why?
| Drug Administration Schedule | 2 | 2008 | 718 | 0.080 |
Why?
| Growth Hormone | 4 | 1992 | 103 | 0.080 |
Why?
| Communicable Diseases | 1 | 1990 | 129 | 0.080 |
Why?
| Brain Ischemia | 1 | 2011 | 299 | 0.080 |
Why?
| Insulin Resistance | 1 | 2016 | 1072 | 0.070 |
Why?
| Host-Parasite Interactions | 1 | 2009 | 95 | 0.070 |
Why?
| Kinetics | 2 | 2003 | 1550 | 0.070 |
Why?
| Inhibitory Postsynaptic Potentials | 1 | 2007 | 28 | 0.070 |
Why?
| Endoplasmic Reticulum | 1 | 2009 | 234 | 0.070 |
Why?
| Lymphotoxin-alpha | 2 | 2000 | 9 | 0.070 |
Why?
| Mice, Inbred Strains | 1 | 2008 | 396 | 0.070 |
Why?
| Granuloma, Respiratory Tract | 1 | 2007 | 12 | 0.070 |
Why?
| Glucans | 1 | 2007 | 25 | 0.070 |
Why?
| Rats, Inbred Strains | 5 | 1995 | 354 | 0.070 |
Why?
| Muscle, Skeletal | 2 | 2014 | 1472 | 0.070 |
Why?
| Recombinant Proteins | 5 | 2004 | 1233 | 0.070 |
Why?
| Amino Acid Chloromethyl Ketones | 1 | 2006 | 22 | 0.070 |
Why?
| Interleukin 1 Receptor Antagonist Protein | 4 | 2004 | 253 | 0.060 |
Why?
| Antigen-Antibody Complex | 1 | 2005 | 88 | 0.060 |
Why?
| Sleep Disorders, Circadian Rhythm | 1 | 2005 | 37 | 0.060 |
Why?
| Mice, Inbred BALB C | 1 | 2008 | 1151 | 0.060 |
Why?
| Sick Role | 1 | 2005 | 18 | 0.060 |
Why?
| Evolution, Molecular | 1 | 2009 | 437 | 0.060 |
Why?
| History, 19th Century | 1 | 2004 | 54 | 0.060 |
Why?
| Prosencephalon | 1 | 2004 | 45 | 0.060 |
Why?
| Organ Size | 1 | 2005 | 435 | 0.060 |
Why?
| Reaction Time | 3 | 1997 | 376 | 0.060 |
Why?
| Adipose Tissue, Brown | 1 | 2004 | 43 | 0.060 |
Why?
| History, 21st Century | 1 | 2004 | 160 | 0.060 |
Why?
| Codon | 1 | 2004 | 86 | 0.060 |
Why?
| Immunoglobulin G | 2 | 2000 | 774 | 0.060 |
Why?
| Cats | 2 | 1995 | 193 | 0.050 |
Why?
| Prolactin | 3 | 1994 | 95 | 0.050 |
Why?
| History, 20th Century | 1 | 2004 | 265 | 0.050 |
Why?
| Polyethylene Glycols | 1 | 2008 | 561 | 0.050 |
Why?
| Signal Transduction | 2 | 2014 | 4521 | 0.050 |
Why?
| Nervous System | 1 | 2003 | 63 | 0.050 |
Why?
| Female | 7 | 2020 | 59507 | 0.050 |
Why?
| Interferons | 2 | 1994 | 151 | 0.050 |
Why?
| Biology | 1 | 2023 | 78 | 0.050 |
Why?
| Neural Inhibition | 1 | 2003 | 140 | 0.050 |
Why?
| Restraint, Physical | 1 | 2002 | 67 | 0.050 |
Why?
| Vasoactive Intestinal Peptide | 2 | 1994 | 15 | 0.050 |
Why?
| Spleen | 2 | 2000 | 484 | 0.050 |
Why?
| Osmolar Concentration | 4 | 1994 | 173 | 0.050 |
Why?
| In Vitro Techniques | 3 | 2010 | 1013 | 0.050 |
Why?
| Models, Biological | 4 | 1999 | 1630 | 0.050 |
Why?
| Adrenocorticotropic Hormone | 3 | 2005 | 129 | 0.050 |
Why?
| Orthomyxoviridae Infections | 1 | 2001 | 54 | 0.050 |
Why?
| Nuclease Protection Assays | 1 | 2000 | 5 | 0.050 |
Why?
| Proto-Oncogene Proteins | 1 | 2004 | 610 | 0.050 |
Why?
| Adipose Tissue | 1 | 2004 | 539 | 0.040 |
Why?
| Biological Factors | 2 | 1990 | 35 | 0.040 |
Why?
| Evoked Potentials | 2 | 2010 | 108 | 0.040 |
Why?
| Neuroprotective Agents | 1 | 2000 | 105 | 0.040 |
Why?
| Hippocampus | 1 | 2003 | 695 | 0.040 |
Why?
| Sex Factors | 2 | 2014 | 1717 | 0.040 |
Why?
| Prognosis | 1 | 2006 | 3334 | 0.040 |
Why?
| Pain | 2 | 2014 | 710 | 0.040 |
Why?
| Antigens, Viral | 1 | 1999 | 176 | 0.040 |
Why?
| Anxiety | 2 | 2014 | 842 | 0.040 |
Why?
| Microinjections | 2 | 2010 | 77 | 0.040 |
Why?
| Ocular Physiological Phenomena | 1 | 1997 | 11 | 0.040 |
Why?
| Cell Differentiation | 1 | 2004 | 1699 | 0.040 |
Why?
| Fourier Analysis | 1 | 1997 | 39 | 0.040 |
Why?
| Drug Interactions | 2 | 2007 | 340 | 0.030 |
Why?
| Antibodies, Monoclonal | 1 | 2003 | 1270 | 0.030 |
Why?
| Rest | 1 | 1997 | 103 | 0.030 |
Why?
| Posture | 1 | 1997 | 153 | 0.030 |
Why?
| Capillary Permeability | 2 | 2007 | 135 | 0.030 |
Why?
| CX3C Chemokine Receptor 1 | 1 | 2015 | 17 | 0.030 |
Why?
| Rotarod Performance Test | 1 | 2015 | 17 | 0.030 |
Why?
| Psychomotor Disorders | 1 | 2015 | 17 | 0.030 |
Why?
| Fluoresceins | 1 | 2015 | 46 | 0.030 |
Why?
| Maze Learning | 1 | 2015 | 86 | 0.030 |
Why?
| Acoustic Stimulation | 1 | 1997 | 315 | 0.030 |
Why?
| Cell Adhesion Molecules | 2 | 1993 | 168 | 0.030 |
Why?
| Pilot Projects | 1 | 2019 | 1370 | 0.030 |
Why?
| Exploratory Behavior | 1 | 2015 | 82 | 0.030 |
Why?
| Molecular Sequence Data | 3 | 1999 | 2791 | 0.030 |
Why?
| Electromyography | 2 | 2011 | 326 | 0.030 |
Why?
| Macaca mulatta | 1 | 1995 | 131 | 0.030 |
Why?
| Macrophage Activation | 1 | 2015 | 164 | 0.030 |
Why?
| Goats | 1 | 1994 | 26 | 0.030 |
Why?
| Sciatic Neuropathy | 1 | 2014 | 24 | 0.030 |
Why?
| Acetylmuramyl-Alanyl-Isoglutamine | 1 | 1993 | 12 | 0.030 |
Why?
| Pain Threshold | 1 | 2014 | 67 | 0.030 |
Why?
| Green Fluorescent Proteins | 1 | 2015 | 373 | 0.030 |
Why?
| Dogs | 1 | 1995 | 334 | 0.030 |
Why?
| Bronchoalveolar Lavage Fluid | 2 | 2007 | 589 | 0.030 |
Why?
| Temperature | 2 | 1999 | 575 | 0.030 |
Why?
| Case-Control Studies | 1 | 2020 | 3005 | 0.030 |
Why?
| Leukocytes, Mononuclear | 1 | 2015 | 493 | 0.030 |
Why?
| Anorexia | 1 | 1992 | 18 | 0.030 |
Why?
| Consensus Sequence | 1 | 1992 | 70 | 0.030 |
Why?
| Prostaglandin D2 | 1 | 1992 | 21 | 0.030 |
Why?
| Cholecystokinin | 1 | 1991 | 15 | 0.020 |
Why?
| Chromatography, Liquid | 1 | 2013 | 348 | 0.020 |
Why?
| Flow Cytometry | 1 | 2015 | 1086 | 0.020 |
Why?
| Sermorelin | 1 | 1991 | 2 | 0.020 |
Why?
| Electrooculography | 1 | 2011 | 10 | 0.020 |
Why?
| Amino Acid Sequence | 2 | 1993 | 1988 | 0.020 |
Why?
| Dinoprostone | 1 | 1992 | 184 | 0.020 |
Why?
| Middle Aged | 3 | 2020 | 26757 | 0.020 |
Why?
| Reference Values | 2 | 1991 | 742 | 0.020 |
Why?
| Pro-Opiomelanocortin | 1 | 1990 | 17 | 0.020 |
Why?
| Peptidoglycan | 1 | 1990 | 25 | 0.020 |
Why?
| Adult | 3 | 2020 | 30548 | 0.020 |
Why?
| Feedback | 1 | 1990 | 144 | 0.020 |
Why?
| Neisseria gonorrhoeae | 1 | 1990 | 20 | 0.020 |
Why?
| Diabetes Mellitus, Experimental | 1 | 1991 | 162 | 0.020 |
Why?
| Acetylcholine | 1 | 2010 | 167 | 0.020 |
Why?
| Peptide PHI | 1 | 1989 | 4 | 0.020 |
Why?
| Gene Knock-In Techniques | 1 | 2009 | 46 | 0.020 |
Why?
| Cross-Sectional Studies | 1 | 2019 | 4409 | 0.020 |
Why?
| Blood | 1 | 1990 | 96 | 0.020 |
Why?
| Acute-Phase Proteins | 1 | 1989 | 64 | 0.020 |
Why?
| Transcription, Genetic | 1 | 1995 | 1316 | 0.020 |
Why?
| Surveys and Questionnaires | 1 | 2020 | 4625 | 0.020 |
Why?
| Interferon-gamma | 3 | 1999 | 722 | 0.020 |
Why?
| Glutamic Acid | 1 | 2010 | 211 | 0.020 |
Why?
| Adenosine | 1 | 2010 | 202 | 0.020 |
Why?
| Animals, Newborn | 1 | 1990 | 777 | 0.020 |
Why?
| Cells, Cultured | 2 | 2009 | 3890 | 0.020 |
Why?
| Bicuculline | 1 | 2007 | 21 | 0.020 |
Why?
| GABA Antagonists | 1 | 2007 | 32 | 0.020 |
Why?
| Dose-Response Relationship, Radiation | 1 | 2007 | 128 | 0.020 |
Why?
| Excitatory Amino Acid Antagonists | 1 | 2007 | 87 | 0.020 |
Why?
| Peptides | 1 | 1992 | 848 | 0.020 |
Why?
| Patch-Clamp Techniques | 1 | 2007 | 241 | 0.020 |
Why?
| Electric Stimulation | 1 | 2007 | 252 | 0.020 |
Why?
| Peroxidase | 1 | 2007 | 157 | 0.020 |
Why?
| Staphylococcus aureus | 1 | 1990 | 385 | 0.020 |
Why?
| Arthus Reaction | 1 | 2005 | 9 | 0.020 |
Why?
| Permeability | 1 | 2005 | 148 | 0.020 |
Why?
| Young Adult | 1 | 2020 | 10463 | 0.020 |
Why?
| Fibroblasts | 1 | 2009 | 838 | 0.020 |
Why?
| Adolescent | 2 | 2020 | 17808 | 0.010 |
Why?
| Leukocytes | 1 | 2005 | 277 | 0.010 |
Why?
| Aged | 2 | 2019 | 19094 | 0.010 |
Why?
| Cell Count | 1 | 2004 | 305 | 0.010 |
Why?
| Fatty Acid-Binding Proteins | 1 | 2004 | 60 | 0.010 |
Why?
| Lung | 2 | 2007 | 3546 | 0.010 |
Why?
| Polysomnography | 1 | 2004 | 139 | 0.010 |
Why?
| Wnt Proteins | 1 | 2004 | 135 | 0.010 |
Why?
| Pulmonary Alveoli | 1 | 2005 | 372 | 0.010 |
Why?
| Intercellular Adhesion Molecule-1 | 2 | 1993 | 154 | 0.010 |
Why?
| HLA-DR Antigens | 2 | 1993 | 220 | 0.010 |
Why?
| Tumor Cells, Cultured | 2 | 1993 | 854 | 0.010 |
Why?
| Lymphocytes | 2 | 1995 | 332 | 0.010 |
Why?
| Nitric Oxide | 1 | 2005 | 824 | 0.010 |
Why?
| Pneumonia | 1 | 2005 | 566 | 0.010 |
Why?
| Carrier Proteins | 1 | 2004 | 696 | 0.010 |
Why?
| Tissue Distribution | 1 | 1999 | 285 | 0.010 |
Why?
| Telemetry | 1 | 1999 | 36 | 0.010 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 928 | 0.010 |
Why?
| Diet | 1 | 2004 | 1080 | 0.010 |
Why?
| NF-kappa B | 1 | 1999 | 636 | 0.010 |
Why?
| Base Sequence | 1 | 1999 | 2118 | 0.010 |
Why?
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1995 | 14 | 0.010 |
Why?
| Organ Specificity | 1 | 1995 | 268 | 0.010 |
Why?
| Immune Sera | 1 | 1994 | 79 | 0.010 |
Why?
| Interferon-beta | 1 | 1994 | 79 | 0.010 |
Why?
| DNA Primers | 1 | 1995 | 514 | 0.010 |
Why?
| Interferon Type I | 1 | 1994 | 128 | 0.010 |
Why?
| Interferon-alpha | 1 | 1994 | 187 | 0.010 |
Why?
| Hot Temperature | 1 | 1994 | 304 | 0.010 |
Why?
| Colon | 1 | 1994 | 233 | 0.010 |
Why?
| Neuroblastoma | 1 | 1993 | 132 | 0.010 |
Why?
| Polymerase Chain Reaction | 1 | 1995 | 994 | 0.010 |
Why?
| Depression, Chemical | 1 | 1991 | 22 | 0.010 |
Why?
| Recombinant Fusion Proteins | 1 | 1994 | 617 | 0.010 |
Why?
| Sensitivity and Specificity | 1 | 1995 | 1691 | 0.010 |
Why?
| Leukocyte Count | 1 | 1990 | 292 | 0.010 |
Why?
| Antiviral Agents | 1 | 1994 | 646 | 0.000 |
Why?
| Neutrophils | 1 | 1990 | 1163 | 0.000 |
Why?
| Insulin | 1 | 1991 | 2079 | 0.000 |
Why?
|
|
Opp's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|